Zoetis (ZOE) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ZOE Analyst Ratings

Moderate Buy

7 Buy

3 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Zoetis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ZOE Stock 12 Month Forecast

Average Price Target

$150.50

Based on 10 Wall Street analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is $150.50 with a high forecast of $175.99 and a low forecast of $121.84. The average price target represents a ― change from the last price of ―.

eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCwgLWFwcGxlLXN5c3RlbSwgQmxpbmtNYWNTeXN0ZW1Gb250LCBTZWdvZSBVSSwgUm9ib3RvLCBIZWx2ZXRpY2EsIEFyaWFsLCBzYW5zLXNlcmlmLCBBcHBsZSBDb2xvciBFbW9qaSwgU2Vnb2UgVUkgRW1vamksIFNlZ29lIFVJIFN5bWJvbCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==

Highest Price Target$175.99

Average Price Target$150.50

Lowest Price Target$121.84

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

09/12/25

Zoetis Positioned for Growth with Innovative Veterinary Pharmaceuticals and Strategic Pipeline Advancements

Unknown Analyst

Argus Research

Not Ranked

Argus Research

CHF151.3

Buy

―

Reiterated

09/09/25

Argus Research Sticks to Its Buy Rating for Zoetis (ZTS)

Jonathan Block

Stifel Nicolaus

CHF123.43

Hold

―

Reiterated

09/03/25

Stifel Nicolaus Reaffirms Their Hold Rating on Zoetis (ZTS)

Bryce Generon

TR | OpenAI - 4o

CHF138.56→CHF137.76

Buy

―

Reiterated

09/03/25

AI Generated ArticleAI Generated Article

Mark Massaro

BTIG

CHF159.26

Buy

―

Reiterated

08/21/25

Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)

David Westenberg

Piper Sandler

CHF167.23→CHF171.21

Buy

―

Reiterated

08/11/25

Piper Sandler Keeps Their Buy Rating on Zoetis (ZTS)

Daniel Clark

Leerink Partners

CHF123.43→CHF121.84

Hold

―

Reiterated

08/06/25

Leerink Partners Keeps Their Hold Rating on Zoetis (ZTS)

Andrea Alfonso

UBS

CHF135.37→CHF131.39

Hold

―

Reiterated

08/06/25

UBS Sticks to Its Hold Rating for Zoetis (ZTS)

Steve Scala

TD Cowen

CHF160.86

Buy

―

Assigned

08/05/25

TD Cowen Reaffirms Their Buy Rating on Zoetis (ZTS)

Erin Wright

Morgan Stanley

CHF189.52→CHF175.99

Buy

―

Reiterated

07/29/25

Morgan Stanley Remains a Buy on Zoetis (ZTS)

Michael Ryskin

Bank of America Securities

CHF159.26

Buy

―

Reiterated

07/10/25

Zoetis Maintains Strong Market Position Despite New Competition, Analyst Recommends Buy

Sidharth Sahoo

HSBC

CHF179.17→CHF143.34

Buy

―

Reiterated

04/28/25

Zoetis price target lowered to $180 from $225 at HSBCZoetis price target lowered to $180 from $225 at HSBC

Balaji Prasad

Barclays

CHF192.71

Buy

―

Reiterated

02/12/25

Barclays Sticks to Their Buy Rating for Zoetis (ZTS)

Chris Schott

J.P. Morgan

CHF179.17→CHF183.15

Buy

―

Reiterated

10/11/24

Zoetis Inc. (ZTS) PT Raised to $230 at JPMorganJPMorgan analyst Chris Schott raised the price target on Zoetis Inc. (NYSE: ZTS) to $230.00 (from $225.00) while maintaining a Overweight rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

09/12/25

Zoetis Positioned for Growth with Innovative Veterinary Pharmaceuticals and Strategic Pipeline Advancements

Unknown Analyst

Argus Research

Not Ranked

Argus Research

CHF151.3

Buy

―

Reiterated

09/09/25

Argus Research Sticks to Its Buy Rating for Zoetis (ZTS)

Jonathan Block

Stifel Nicolaus

CHF123.43

Hold

―

Reiterated

09/03/25

Stifel Nicolaus Reaffirms Their Hold Rating on Zoetis (ZTS)

Bryce Generon

TR | OpenAI - 4o

CHF138.56→CHF137.76

Buy

―

Reiterated

09/03/25

AI Generated ArticleAI Generated Article

Mark Massaro

BTIG

CHF159.26

Buy

―

Reiterated

08/21/25

Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)

David Westenberg

Piper Sandler

CHF167.23→CHF171.21

Buy

―

Reiterated

08/11/25

Piper Sandler Keeps Their Buy Rating on Zoetis (ZTS)

Daniel Clark

Leerink Partners

CHF123.43→CHF121.84

Hold

―

Reiterated

08/06/25

Leerink Partners Keeps Their Hold Rating on Zoetis (ZTS)

Andrea Alfonso

UBS

CHF135.37→CHF131.39

Hold

―

Reiterated

08/06/25

UBS Sticks to Its Hold Rating for Zoetis (ZTS)

Steve Scala

TD Cowen

CHF160.86

Buy

―

Assigned

08/05/25

TD Cowen Reaffirms Their Buy Rating on Zoetis (ZTS)

Erin Wright

Morgan Stanley

CHF189.52→CHF175.99

Buy

―

Reiterated

07/29/25

Morgan Stanley Remains a Buy on Zoetis (ZTS)

Michael Ryskin

Bank of America Securities

CHF159.26

Buy

―

Reiterated

07/10/25

Zoetis Maintains Strong Market Position Despite New Competition, Analyst Recommends Buy

Sidharth Sahoo

HSBC

CHF179.17→CHF143.34

Buy

―

Reiterated

04/28/25

Zoetis price target lowered to $180 from $225 at HSBCZoetis price target lowered to $180 from $225 at HSBC

Balaji Prasad

Barclays

CHF192.71

Buy

―

Reiterated

02/12/25

Barclays Sticks to Their Buy Rating for Zoetis (ZTS)

Chris Schott

J.P. Morgan

CHF179.17→CHF183.15

Buy

―

Reiterated

10/11/24

Zoetis Inc. (ZTS) PT Raised to $230 at JPMorganJPMorgan analyst Chris Schott raised the price target on Zoetis Inc. (NYSE: ZTS) to $230.00 (from $225.00) while maintaining a Overweight rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zoetis

1 Month

xxx

Success Rate

14/24 ratings generated profit

Average Return

+2.15%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +2.15% per trade.

3 Months

xxx

Success Rate

14/24 ratings generated profit

Average Return

+4.29%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +4.29% per trade.

1 Year

Erin WrightMorgan Stanley

Success Rate

16/24 ratings generated profit

Average Return

+13.57%

reiterated a buy rating 2 months ago

Copying Erin Wright's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +13.57% per trade.

2 Years

xxx

Success Rate

15/24 ratings generated profit

Average Return

+35.69%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +35.69% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZOE Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ZOE has received 14 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ZOE average Analyst price target in the past 3 months is 150.50.

Each month's total comprises the sum of three months' worth of ratings.

ZOE Financial Forecast

ZOE Earnings Forecast

Next quarter’s earnings estimate for ZOE is $1.29 with a range of $1.24 to $1.34. The previous quarter’s EPS was $1.39. ZOE beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year ZOE has Outperformed its overall industry.

ZOE Sales Forecast

Next quarter’s sales forecast for ZOE is $1.92B with a range of $1.88B to $1.94B. The previous quarter’s sales results were $1.95B. ZOE beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ZOE has Outperformed its overall industry.

ZOE Stock Forecast FAQ

What is CH:ZOE’s average 12-month price target, according to analysts?

Based on analyst ratings, Zoetis’s 12-month average price target is 150.50.

What is CH:ZOE’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:ZOE, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Zoetis a Buy, Sell or Hold?

Zoetis has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 3 hold ratings and 0 sell ratings.

What is Zoetis’s share price target?

The average share price target for Zoetis is 150.50. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $175.99 ,and the lowest forecast is $121.84. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about Zoetis?

Zoetis’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Zoetis?

To buy shares of CH:ZOE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Zoetis (ZOE) Stock Forecast & Price Target

ZOE Analyst Ratings

ZOE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zoetis

ZOE Analyst Recommendation Trends

ZOE Financial Forecast

ZOE Earnings Forecast

ZOE Sales Forecast

ZOE Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts